Clinical trial
Evaluate the Safety and Anti-Hypertensive Efficacy of Hyzaar(R) In Patients With…
NCT00400218 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00400218 |
|---|---|
| Title | Evaluate the Safety and Anti-Hypertensive Efficacy of Hyzaar(R) In Patients With Mild To Moderate Essential Hypertension (0954A-323) |
| Official title | Evaluate the Safety and Tolerability of Hyzaar(R) (Losartan 50 Mg/ Hydrochlorothiazide 12.5 Mg) In the Treatment of Hypertension |
| Lead sponsor | Organon and Co, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | MK0954A, hydrochlorothiazide (+) losartan potassium / Duration of Treatment: 12 Weeks |
| Enrollment | 62 |
| Start date | Sep 1, 2005 |
| Primary completion | Jul 1, 2006 |
| Completion | Jul 19, 2006 |
| First posted | Nov 16, 2006 |
| Last update posted | Aug 15, 2024 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: